Stockholders Equity and StockBased Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2022 |
|---|
| Stockholders Equity and StockBased Compensation |
|
| Schedule Of Share-based Compensation, Stock Options, Activity |
Expected volatility |
|
97.58%-115.37 |
% |
Risk free interest rate |
|
1.02%-3.275 |
% |
Dividend yield rate |
|
|
0 |
|
Weighted average years |
|
2 - 6 years |
|
Closing price per share - common stock |
|
$5.93 - $6.27 |
|
|
| Schedule Of Stock Option Transactions Of The Employees |
|
|
Options
Outstanding
|
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Grant Date
Fair Value
|
|
Beginning of the year - January 1, 2022 |
|
|
538,713 |
|
|
$ |
18.51 |
|
|
$ |
12.92 |
|
Granted |
|
|
18,852 |
|
|
|
6.17 |
|
|
|
3.98 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeited |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Expired |
|
|
(31,662 |
) |
|
|
7.29 |
|
|
|
2.37 |
|
End of the period - September 30, 2022 |
|
|
525,903 |
|
|
$ |
18.74 |
|
|
$ |
13.23 |
|
Options exercisable |
|
|
514,513 |
|
|
$ |
19.03 |
|
|
$ |
13.43 |
|
|
| Schedule Of Non-vested Options, Activity |
|
|
Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Fair Value
Grant Date
|
|
Non-vested - December 31, 2021 |
|
|
11,766 |
|
|
$ |
5.71 |
|
|
$ |
4.25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted |
|
|
18,852 |
|
|
|
6.17 |
|
|
|
3.98 |
|
Vested |
|
|
(19,228 |
) |
|
|
6.17 |
|
|
|
3.90 |
|
Forfeited |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Non-vested- September 30, 2022 |
|
|
11,390 |
|
|
$ |
5.69 |
|
|
$ |
4.39 |
|
|
| Schedule Of Stock Options Exercisable |
|
|
|
Stock Options Outstanding |
|
|
Stock Options Vested |
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
Average |
|
|
|
|
|
|
|
|
Average |
|
|
|
|
|
|
|
|
|
|
Remaining |
|
|
|
|
|
Weighted |
|
|
Remaining |
|
|
|
|
|
Weighted |
|
|
|
|
Contractual |
|
|
Number |
|
|
Average |
|
|
Contractual |
|
|
Number |
|
|
Average |
|
|
|
|
Life |
|
|
of |
|
|
Exercise |
|
|
Life |
|
|
of |
|
|
Exercise |
|
|
Exercise Prices |
|
-Years |
|
|
Awards |
|
|
Price |
|
|
-Years |
|
|
Awards |
|
|
Price |
|
$ |
3.82-$9.00 |
|
|
5.69 |
|
|
|
128,407 |
|
|
$ |
4.81 |
|
|
|
5.35 |
|
|
|
117,017 |
|
|
$ |
$4.72 |
|
$ |
9.01-$12.48 |
|
|
5.85 |
|
|
|
116,544 |
|
|
$ |
10.80 |
|
|
|
5.85 |
|
|
|
116,544 |
|
|
$ |
$10.80 |
|
$ |
12.49-$24.00 |
|
|
4.37 |
|
|
|
195,090 |
|
|
$ |
14.23 |
|
|
|
4.37 |
|
|
|
195,090 |
|
|
$ |
$14.23 |
|
$ |
24.01-$72.00 |
|
|
2.97 |
|
|
|
62,771 |
|
|
$ |
55.07 |
|
|
|
2.97 |
|
|
|
62,771 |
|
|
$ |
$55.07 |
|
$ |
72.01-$75.60 |
|
|
2.40 |
|
|
|
23,091 |
|
|
$ |
75.59 |
|
|
|
2.40 |
|
|
|
23,091 |
|
|
$ |
$75.59 |
|
|
Total |
|
|
4.77 |
|
|
|
525,903 |
|
|
$ |
18.74 |
|
|
|
4.67 |
|
|
|
514,513 |
|
|
$ |
$19.03 |
|
|
| Summary Of RSAs Activity |
|
|
|
|
|
Weighted |
|
|
|
Number |
|
|
Average |
|
|
|
of |
|
|
Grant Date |
|
|
|
Shares |
|
|
Fair Value |
|
Total RSAs outstanding at January 1, 2022 |
|
|
377,176 |
|
|
$ |
10.69 |
|
Total RSAs granted |
|
|
— |
|
|
$ |
— |
|
Total RSAs vested |
|
|
— |
|
|
$ |
— |
|
Total RSAs forfeited |
|
|
— |
|
|
$ |
— |
|
Total unvested RSAs outstanding at September 30, 2022 |
|
|
377,176 |
|
|
$ |
10.69 |
|
|
| Schedule vesting for outstanding RSA |
|
|
Year Ending December 31, |
|
|
|
2022 |
|
|
2023 |
|
|
2024 |
|
|
Total |
|
Scheduled vesting |
|
|
62,862 |
|
|
|
62,864 |
|
|
|
62,862 |
|
|
|
188,588 |
|
|
| Schedule Of Stock Based Compensation Expense |
|
|
For the Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
General and administrative expenses |
|
$ |
0.2 |
|
|
$ |
0.1 |
|
|
$ |
0.6 |
|
|
$ |
0.3 |
|
Total stock-based compensation expense |
|
$ |
0.2 |
|
|
$ |
0.1 |
|
|
$ |
0.6 |
|
|
$ |
0.3 |
|
|